EUVIMEDObjevte EUVIMED
Open access

Intra‐Accumbal Infusions of an α 2 ‐Adrenoceptor Agonist and an α 2 ‐Adrenoceptor Antagonist Respectively Inhibit and Enhance Acetylcholine but Not Dopamine Efflux in the Nucleus Accumbens of Freely Moving Rats

Kazuki Arai, Hiroki Kawashima, Yuri Aono, Yasuhiro Kosuge, John L Waddington, Tadashi Saigusa

Synapse · 2026

DOI: 10.1002/syn.70054 ↗

At a glance

Journal article in Synapse, 2026. Written by Kazuki Arai and 5 co-authors. Institution: Pharmacology and Dental Pharmacology, Nihon University Graduate School of Dentistry at Matsudo, Matsudo, Chiba, Japan. Major MEDLINE topics: Nucleus Accumbens, Acetylcholine, Dopamine, Adrenergic alpha-2 Receptor Agonists. 39 references. The full text is freely available in PubMed Central. Funded by: Japan Society for the Promotion of Science, The Smoking Research Foundation, Japan.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Though the nucleus accumbens (NAc) is a key terminal region of the mesolimbic dopaminergic system, it is also innervated by noradrenergic inputs from the ventral medulla and contains intrinsic cholinergic neurons. However, the roles of α‐adrenoceptors in regulating basal accumbal cholinergic activity remain unclear. This study employed in vivo microdialysis in unanesthetized rats to investigate the role of α 1 ‐ and α 2 ‐adrenoceptors in modulating extracellular acetylcholine (ACh) levels in the NAc. Accumbal administration of the α 2 ‐agonist UK 14304 (30.0 and 300.0 pmol) and the α 2 ‐antagonist RX 821002 (0.6, 600.0, and 6000.0 pmol) dose‐dependently decreased and increased accumbal ACh efflux, respectively. Neither compound (UK 14304: 300.0 pmol; RX 821002: 6000.0 pmol) affected basal accumbal dopamine levels. Co‐administration of RX 821002 (0.6 pmol) blocked the UK 14304 (300.0 pmol)‐induced reduction in ACh efflux, whereas UK 14304 (30.0 pmol) inhibited the RX 821002 (6000.0 pmol)‐induced increase. Intraperitoneal administration of RX 821002 (1.0 mg/kg), but not UK 14304 (2.5 mg/kg), increased accumbal ACh efflux, which was inhibited by intra‐accumbal infusion of UK 14304 (30.0 pmol). Neither the α 1 ‐agonist methoxamine (0.24 pmol) nor the α 1 ‐antagonist prazosin (6.0 pmol) altered accumbal ACh levels. Doses of drugs infused indicate the total amount (mol) during the 60‐min infusion. These findings indicate that RX 821002 enhances ACh efflux in the NAc by blocking accumbal α 2 ‐adrenoceptor‐mediated inhibition of ACh release. Given that reduced accumbal ACh levels have been implicated in cognitive impairment, systemic administration of α 2 ‐adrenoceptor antagonists should be investigated for their potential to improve such deficits in experimental models.

Subjects

MeSH terms (MEDLINE)

Nucleus AccumbensAcetylcholineDopamineAdrenergic alpha-2 Receptor AgonistsAdrenergic alpha-2 Receptor AntagonistsAnimalsMaleRatsMicrodialysisIdazoxanDose-Response Relationship, DrugDioxanesBrimonidine TartrateRats, Sprague-DawleyReceptors, Adrenergic, alpha-2

Author keywords

acetylcholinedopaminein vivo microdialysisnucleus accumbensratα2‐adrenoceptors

Substances

AcetylcholineDopamineAdrenergic alpha-2 Receptor AgonistsAdrenergic alpha-2 Receptor AntagonistsIdazoxan2-methoxyidazoxanDioxanesBrimonidine Tartrate(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxaneReceptors, Adrenergic, alpha-2

Authors and institutions

  • Pharmacology and Dental Pharmacology, Nihon University Graduate School of Dentistry at Matsudo, Matsudo, Chiba, Japan.
  • Department of Pharmacology, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, Japan.
  • Laboratory of Pharmacology, Nihon University School of Pharmacy, Funabashi, Chiba, Japan.
  • School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Funding

  • Japan Society for the Promotion of Science
  • The Smoking Research Foundation, Japan

Cite

APA

Arai, K., Kawashima, H., Aono, Y., Kosuge, Y., Waddington, J. L., & Saigusa, T. (2026). Intra‐Accumbal Infusions of an α 2 ‐Adrenoceptor Agonist and an α 2 ‐Adrenoceptor Antagonist Respectively Inhibit and Enhance Acetylcholine but Not Dopamine Efflux in the Nucleus Accumbens of Freely Moving Rats. Synapse. https://doi.org/10.1002/syn.70054

Vancouver

Arai K, Kawashima H, Aono Y, Kosuge Y, Waddington JL, Saigusa T. Intra‐Accumbal Infusions of an α 2 ‐Adrenoceptor Agonist and an α 2 ‐Adrenoceptor Antagonist Respectively Inhibit and Enhance Acetylcholine but Not Dopamine Efflux in the Nucleus Accumbens of Freely Moving Rats. Synapse. 2026. doi:10.1002/syn.70054

BibTeX
@article{Arai2026,
  author = {Arai, Kazuki and Kawashima, Hiroki and Aono, Yuri and Kosuge, Yasuhiro and Waddington, John L and Saigusa, Tadashi},
  title = {Intra‐Accumbal Infusions of an α 2 ‐Adrenoceptor Agonist and an α 2 ‐Adrenoceptor Antagonist Respectively Inhibit and Enhance Acetylcholine but Not Dopamine Efflux in the Nucleus Accumbens of Freely Moving Rats},
  journal = {Synapse},
  year = {2026},
  doi = {10.1002/syn.70054}
}
Start for free →